DrugPatentWatch Database Preview
Drugs in Development Information for Talinolol
Drug Development Status for Talinolol: Patents, clinical trial progress, indications
Talinolol is an investigational drug.
There have been 4 clinical trials for Talinolol.
The most recent clinical trial was a Phase 1 trial, which was initiated on April 1st 2011.
The most common disease conditions in clinical trials are Obesity, Morbid and [disabled in preview]. The leading clinical trial sponsors are University Medicine Greifswald, Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH, and Matthias Schwab.
Summary for Talinolol
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 703 |
| WIPO Patent Applications | 456 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 1 (2011-04-01) |
| Vendors | 30 |
Recent Clinical Trials for Talinolol
| Title | Sponsor | Phase |
|---|---|---|
| Open Label Study for the Functional Characterization of Drug Metabolism and Transport | Matthias Schwab | Phase 1 |
| Absorption of Paracetamol, Talinolol and Amoxicillin After Oral Administration Using Non-caloric and Caloric Water | University Medicine Greifswald | Phase 1 |
| Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug Pharmacokinetics | Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH | Phase 1 |
Clinical Trial Summary for Talinolol
Top disease conditions for Talinolol
Top clinical trial sponsors for Talinolol
US Patents for Talinolol
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
